← Leaderboards
Elizabeth S. Yeh
Indiana University Indianapolis
$3,779,725
Attributed
$4,168,756
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $889.7K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,168,756 · 6
By mechanism
R01$3,182,548 · 2
R21$433,218 · 1
T32$344,844 · 1
R03$158,500 · 1
F32$49,646 · 1
Top collaborators
- Thomas D. Hurley1 shared
- Yao-Ying Ma1 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- David W. Clapp$30,065,006
- Randal J. Kaufman$37,816,764
- Mark H. Kaplan$27,781,093
- Paul Richard Territo$22,416,914
- Loren J Field$21,917,203
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingPhosphotransferasesSignal TransductionNeoplastic CellExhibitsTumorResponseIn VivoSignal PathwayNeoplasm MetastasisSmall Hairpin RnaMalignant Breast NeoplasmCellsSamplingBreast Cancer ModelDown-RegulationMolecularKnock-DownBreast Cancer Cell LineIn Vivo ModelMammary GlandCell SurvivalImpairmentAutophagocytosis
Grant awards (16)
Tumor cell -TAM Paracrine Signaling in Breast Cancer$447,481
R01 · FY2025 · CA · contact PI
Tumor cell -TAM Paracrine Signaling in Breast Cancer$430,489
R01 · FY2024 · CA · contact PI
IMSD at Indiana University School of Medicine through Inclusive Biomedical Research Training Program$344,844
T32 · FY2024 · GM
Tumor cell -TAM Paracrine Signaling in Breast Cancer$456,441
R01 · FY2023 · CA · contact PI
Novel Kinase Target in Alzheimer's Disease$433,218
R21 · FY2023 · NS · contact PI
HUNK Regulation of IL-4$158,500
R03 · FY2020 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$335,765
R01 · FY2019 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$21,078
R01 · FY2019 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$341,981
R01 · FY2018 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$53,608
R01 · FY2018 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$341,981
R01 · FY2017 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$53,608
R01 · FY2017 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$341,981
R01 · FY2016 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$43,329
R01 · FY2016 · CA · contact PI
Overcoming Resistance in HER2-positive Breast Cancer$314,806
R01 · FY2015 · CA · contact PI
Defining a role for Hunk in oncogenic signaling$49,646
F32 · FY2007 · CA · contact PI